Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa

被引:90
作者
Radwan, Mohamed M. [1 ]
ElSohly, Mahmoud A. [1 ,2 ]
El-Alfy, Abir T. [3 ]
Ahmed, Safwat A. [1 ]
Slade, Desmond [1 ]
Husni, Afeef S. [3 ]
Manly, Susan P. [3 ]
Wilson, Lisa [3 ]
Seale, Suzanne [3 ]
Cutler, Stephen J. [1 ,3 ]
Ross, Samir A. [1 ,3 ]
机构
[1] Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA
[2] Univ Mississippi, Sch Pharm, Dept Pharmaceut & Drug Delivery, University, MS 38677 USA
[3] Univ Mississippi, Sch Pharm, Dept BioMol Sci, University, MS 38677 USA
来源
JOURNAL OF NATURAL PRODUCTS | 2015年 / 78卷 / 06期
关键词
RECEPTOR; CONSTITUENTS; DELTA-9-TETRAHYDROCANNABINOL; DELTA(9)-TETRAHYDROCANNABINOL; METABOLITES; MARIJUANA;
D O I
10.1021/acs.jnatprod.5b00065
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Seven new naturally occurring hydroxylated cannabinoids (1-7), along with the known cannabiripsol (8), have been isolated from the aerial parts of high-potency Cannabis sativa. The structures of the new compounds were determined by 1D and 2D NMR spectroscopic analysis, GC-MS, and HRESIMS as 8 alpha-hydroxy-Delta(9)-tetrahydrocannabinol (1), 8 beta-hydroxy-Delta(9)-tetrahydrocannabinol (2), 10 alpha-hydroxy-Delta(8)-tetrahydrocannabinol (3), 10 beta-hydroxy-Delta(8)-tetrahydrocannabinol (4), 10 alpha-hydroxy-Delta(9,11)-hexahydrocannabinol (5), 9 beta,10 beta-epoxyhexahydrocannabinol (6), and 11-acetoxy-Delta(9)-tetrahydrocannabinolic acid A (7). The binding affinity of isolated compounds 1-8, Delta(9)-tetrahydrocannabinol, and Delta(8)-tetrahydrocannabino1 toward CB1 and CB2 receptors as well as their behavioral effects in a mouse tetrad assay were studied. The results indicated that compound 3, with the highest affinity to the CB1 receptors, exerted the most potent cannabimimetic-like actions in the tetrad assay, while compound 4 showed partial cannabimimetic actions. Compound 2, on the other hand, displayed a dose-dependent hypolocomotive effect only.
引用
收藏
页码:1271 / 1276
页数:6
相关论文
共 36 条
[1]   Structure determination and absolute configuration of cannabichromanone derivatives from high potency Cannabis sativa [J].
Ahmed, Safwat A. ;
Ross, Samir A. ;
Slade, Desmond ;
Radwan, Mohamed M. ;
Khan, Ikhlas A. ;
Elsohly, Mahmoud A. .
TETRAHEDRON LETTERS, 2008, 49 (42) :6050-6053
[2]   Cannabinoid ester constituents from high-potency Cannabis sativa [J].
Ahmed, Safwat A. ;
Ross, Samir A. ;
Slade, Desmond ;
Radwan, Mohamed M. ;
Zulfiqar, Fazila ;
ElSohly, Mahmoud A. .
JOURNAL OF NATURAL PRODUCTS, 2008, 71 (04) :536-542
[3]  
Appendino G, 2008, NAT PROD COMMUN, V3, P1977
[4]   The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration [J].
Ashton, John C. ;
Glass, Michelle .
CURRENT NEUROPHARMACOLOGY, 2007, 5 (02) :73-80
[5]   CB1 cannabinoid receptor antagonists [J].
Barth, F .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 :103-118
[6]   CANNABIRIPSOL - NOVEL CANNABIS CONSTITUENT [J].
BOEREN, EG ;
ELSOHLY, MA ;
TURNER, CE .
EXPERIENTIA, 1979, 35 (10) :1278-1279
[7]   A NEW 9,10-DIHYDROPHENANTHRENEDIONE FROM Cannabis sativa [J].
Cheng, Liang ;
Kong, Deyun ;
Hu, Guang ;
Li, Huiting .
CHEMISTRY OF NATURAL COMPOUNDS, 2010, 46 (05) :710-712
[8]   NMR assignments of the major Cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativa [J].
Choi, YH ;
Hazekamp, A ;
Peltenburg-Looman, AMG ;
Frédérich, M ;
Erkelens, C ;
Lefeber, AWM ;
Verpoorte, R .
PHYTOCHEMICAL ANALYSIS, 2004, 15 (06) :345-354
[9]   Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis [J].
Darmani, NA ;
Johnson, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 488 (1-3) :201-212
[10]  
DEVANE WA, 1988, MOL PHARMACOL, V34, P605